Mertiatide

DB15780InvestigationalSmall molecule

Mertiatide is a radiopharmaceutical reconstituted with sodium pertechnetate for imaging of the kidney. A medication used to image the kidney.

Chemical structure of Mertiatide
Formula / weight
C8H13N3O5S · 263.27 g/mol (avg)

Resolves to

Compound
UNII8NVY8268MYCAS66516-09-4ChEMBLCHEMBL1615778
Structure
InChIKeyRXACEEPNTRHYBQ-UHFFFAOYSA-NSMILESOC(=O)CNC(=O)CNC(=O)CNC(=O)CS

What you can answer from here — as of March 06, 2025

1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2ContraindicationsEach with its own population and attribute set
Sign in
5Marketed productsAcross 4 countries and 2 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Mertiatide, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In